Michelle Tassinari, PA

Michelle Tassinari practices at Barnabas Health Medical Group in Jersey City, New Jersey.

Michelle Tassinari's NPI, 1134674377, was assigned on August 17, 2016. Michelle Tassinari holds New Jersey license 25MP00390400.

Michelle Tassinari's primary practice is Barnabas Health Medical Group, at 100 Town Square Pl, Jersey City, NJ 07310 in Hudson County. The practice phone is (908) 994-5738.

Michelle Tassinari's primary practice is Barnabas Health Medical Group in Jersey City, New Jersey. Michelle Tassinari is also affiliated with Cooperman Barnabas Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Michelle Tassinari to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michelle Tassinari practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical is Michelle Tassinari's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Dmand AI has Michelle Tassinari's licenses on file in 2 states: New Jersey and New York.

Dmand AI lists arthritis, bursitis, joint pain, knee injury and muscle pain, fibromyalgia, and limb pain among the conditions Michelle Tassinari treats.

CMS data shows 401 Medicare services from Michelle Tassinari across 7 procedure codes in 2024, for 105 Medicare patients. Medicare paid $8,034 for them. Every service was in an office.

CMS counts 105 Medicare patients who saw Michelle Tassinari in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michelle Tassinari's median patient age at 65, with 65% women.

In 2024, Michelle Tassinari wrote 543 Medicare Part D claims for 319 patients. 98% of them were for generic drugs. CMS names the drug for 426 of them, across 10 drugs with 11 or more claims each, at $8,544 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Michelle Tassinari for performance year 2024, reported through an alternative payment model (APM). Michelle Tassinari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Michelle Tassinari from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Ferring Pharmaceuticals Inc. paid the most, $87.